Hereditary Breast & Ovarian Cancer

Hereditary breast and ovarian cancer due to mutations in the brca1 and brca2 genes is the most common cause of hereditary forms of both breast and ovarian cancer. Here are the latest discoveries pertaining to these cancers.

January 16, 2022

Exome sequencing identifies RASSF1 and KLK3 germline variants in an Iranian multiple-case breast cancer family.

European Journal of Medical Genetics
Hoda RadmaneshThilo Dörk
January 16, 2022

Advocating for equitable management of hereditary cancer syndromes.

Journal of Genetic Counseling
Rikki Gaber Caffrey
January 16, 2022

Trends in treatment patterns and costs of care among patients with advanced stage cervical cancer.

Gynecologic Oncology
Fernanda B MusaScott D Ramsey
January 15, 2022

Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

European Journal of Human Genetics : EJHG
Eileen O DarengPaul D P Pharoah
January 15, 2022

Attitude towards hereditary cancer risk management among women with cancer in Taiwan.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Su-Ying FangYong Alison Wang
January 13, 2022

Distress screening in endometrial cancer leads to disparity in referral to support services.

Gynecologic Oncology
Hadley W ReidBrittany A Davidson
January 13, 2022
Review

Clinical significance of gene polymorphisms for hereditary predisposition to breast and ovarian cancer (review of literature).

Klinicheskaia laboratornaia diagnostika
D I VodolazhskyI I Fomochkina
January 12, 2022
Open Access

Genetic Variation in MicroRNA-423 Promotes Proliferation, Migration, Invasion, and Chemoresistance in Breast Cancer Cells.

International Journal of Molecular Sciences
Sebastian Morales-PisonHéctor R Contreras
January 10, 2022

Hospital-based ovarian cancer patient traceback program results in minimal genetic testing uptake.

Gynecologic Oncology
Simone WeinmannLeigha Senter
January 10, 2022

Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroups.

Gynecologic Oncology
Douglas I LinJulia A Elvin
January 11, 2022
Review

Creating work environments where people of all genders in gynecologic oncology can thrive: An SGO evidence-based review.

Gynecologic Oncology
S M TemkinS V Blank
January 8, 2022

Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (SI-NETs).

JCO Precision Oncology
Kimberly PerezJennifer Chan
January 8, 2022

Evaluation of TP53 Variants Detected on Peripheral Blood or Saliva Testing: Discerning Germline From Somatic TP53 Variants.

JCO Precision Oncology
Alison SchwartzJudy E Garber

Sign up to follow this feed and discover related papers.

Related Feeds

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma

The cervix contains two types of cells and when cancer arises from squamous cells within the cervix it is cervical squamous cell carcinoma. The endocervix is located just above the body of the cervix and contains glandular cells. When cancer begins here it is called endocervical adenocarcinoma. Here is the latest research on these two types of cancers.

© 2022 Meta ULC. All rights reserved
/feed-previews/hereditary-breast-ovarian-cancer/ae470ab4-3ff6-4778-93bb-3362417487b7